Can-Fite recruiting for psoriasis treatment trial - Globes

Can-Fite recruiting for psoriasis treatment trial Globes Drug developer Can-Fite BioPharma Ltd. (TASE:CFBI) today declared that it has begun recruiting patents for the Phase II/III clinical legal proceeding of its CF101 drug for the treatment of psoriasis . 300 patients will be included in the six-month trial At ... Can-Fite BioPharma Announces the Initiation of diligent Enrolment for the state of matter ... Business Wire (press release) Can-Fite BioPharma Announces the Initiation of diligent Enrolment for the state of matter ... SunHerald.com all xii news articles » Link To Article